國泰集團(603977.SH):當前和今後一個時期是軍民融合發展的戰略機遇期
格隆匯1月4日丨國泰集團(603977.SH)近期投資者關係活動記錄表顯示,當前和今後一個時期是軍民融合發展的戰略機遇期,也是軍民融合由初步融合向深度融合過渡、進而實現跨越發展的關鍵期,國防科技工業領域軍民融合潛力巨大。公司擁有軍民融合行業從業經驗和相關人才隊伍,具有從事軍民融合業務的相對優勢,目前公司主要依託下屬子公司神舟智匯、江西澳科、新餘國泰、拓泓新材和三石有色開展軍民融合相關業務。
未來公司將深耕現有軍民融合產業細分領域,同時藉助公司民爆業務領域競爭優勢,開拓泛民爆類軍工業務,不斷推動公司軍民融合產業縱深發展,力爭在“十四五”末期間公司軍民融合產業打造成公司另一個強有力的發展支柱
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.